The efficacy of the eradication of Helicobacter pylori for quality of life -Multicenter clinical study

Not Applicable

• Conditions: Helicobacter infection without other orgnic disease

• Registration Number: JPRN-UMIN000013060
• Lead Sponsor: Kagoshima University Graduate School of Medical and Dental Sciences, Digestive and Life-style related Disease

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-02-03
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 230

Inclusion Criteria

Not provided

Exclusion Criteria

Patients who are not diagnosed gastro-esophageal reflux disease (GERD) over the grade A of Los Angeles Classification, gastric ulcer, gastric cancer. Patients who are not administrated non steroidal anti-inflammatory drugs (NSAIDs), major or minor tranquilizer, acotiamide every day. Patients with history of gastrectomy. Patients with severe renal or liver dysfunciton. Patients with cancer. Patients who have a history of failure of the first eradication of Helicobacter pylori.

Study & Design

• Study Type: Interventional,observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of quality of life before and after Helicbacter pylori eradication

Secondary Outcome Measures

Name	Time	Method
1.Effect of full dose of administration of proton pump inhibitor for upper abdominal symptoms in before and after eradication of Helicobacter pylori. 2.Evaluation of the successful rate of eradication of Helicobacter pylori by preceding PPI administration before eradication.